Martin Koller
CIK 1573351 · Chief Medical Officer · last filed 2016-02-26
Martin Koller is a Chief Medical Officer who has filed 6 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing, for PRTA, was dated Feb 26, 2016. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $300.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$300.6K
1
6
-$3.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRTA | Chief Medical Officer | 30,000 | $10.02 | $300.6K | -$3.62M | 6 | 2016-02-26 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-26 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2015-11-13 | PRTA | Mixed | — | -$1.75M | EDGAR |
| 2015-09-03 | PRTA | Mixed | — | -$1.47M | EDGAR |
| 2015-03-12 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2014-02-06 | PRTA | Grant (A) | — | $0 | EDGAR |
| 2013-04-02 | PRTA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.